Results 51 to 60 of about 92,418 (213)

The hepatotropic influence of cyclosporine [PDF]

open access: yes, 1990
The effect of cyclosporine on liver regeneration has been investigated in 25 dogs that underwent an end-to-side portacaval shunt (Eck fistula) followed by 4 days continuous infusion of the drug into the left branch of the portal vein.
K. A. Porter   +19 more
core  

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

open access: yesClinical Ophthalmology, 2021
John Sheppard,1 Mark Bergmann,2 Barry A Schechter,3 Jodi Luchs,4 Abayomi Ogundele,5 Paul Karpecki6 1Virginia Eye Consultants, Norfolk, VA, USA; 2Apex Eye, Cincinnati, OH, USA; 3Florida Eye Microsurgical Institute, Boynton Beach, FL, USA; 4Florida Vision ...
Sheppard J   +5 more
doaj  

A meta-analysis of cyclosporine treatment for Stevens–Johnson syndrome/toxic epidermal necrolysis

open access: yes, 2018
Qin Xiang Ng,1,2 Michelle Lee Zhi Qing De Deyn,3 Nandini Venkatanarayanan,4 Collin Yih Xian Ho,2 Wee-Song Yeo,5 1Department of Medicine, National University Hospital, National University Health System, Singapore; 2MOH Holdings Pte Ltd, Singapore ...
Ho CYX   +4 more
core  

Enhanced efficacy of 0.05% cyclosporine a combined with absorbable punctal plugs in Sjögren’s syndrome-associated dry eye: a paired-eye clinical trial

open access: yesFrontiers in Medicine
IntroductionTo compare the efficacy of combination therapy using 0.05% cyclosporine A (CsA) and absorbable punctal plugs with that of CsA monotherapy in patients with Sjögren’s syndrome-associated dry eye (SS-DE) using a paired-eye randomized controlled ...
Yi Dong   +6 more
doaj   +1 more source

Cyclosporine A micellar delivery system for dry eyes

open access: yes, 2016
Han Kang,1,2 Kwang-Ho Cha,1 Wonkyung Cho,1 Junsung Park,1 Hee Jun Park,1 Bo Kyung Sun,1,2 Sang-Min Hyun,1,2 Sung-Joo Hwang1,2 1Yonsei Institute of Pharmaceutical Sciences, 2College of Pharmacy, Yonsei University, Incheon, South Korea Background: The ...
Cho W   +7 more
core  

Update on gingival overgrowth by cyclosporine A in renal transplants. [PDF]

open access: yes, 2007
Severe gingival overgrowth is one of the most frequent side effects in renal transplant patients associated with assumption of cyclosporine A. Several associations with age, sex, dosage, duration of therapy or interval since transplantation have been ...
LO MUZIO L.   +14 more
core  

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

open access: yes, 2013
Karl G Stonecipher,1 Jenny Chia,2 Ahunna Onyenwenyi,2 Linda Villanueva,2 David A Hollander2 1TLC Laser Eye Centers, Greensboro, NC, 2Allergan, Inc., Irvine, CA, USA Background: Dry eye is a multifactorial, symptomatic disease associated with ocular ...
Hollander DA   +4 more
core  

Disseminated granuloma annulare : efficacy of cyclosporine therapy

open access: yes, 2006
Granuloma annulare is an anatomo-clinical entity that is frequently encountered in everyday dermatological practice. We report our experience regarding 4 patients with disseminated granuloma annulare. Each patient was treated with a cycle of cyclosporine
A. Altomare   +7 more
core   +1 more source

Place of cyclosporin A in the therapy of rheumatic diseases

open access: yesСовременная ревматология, 2011
The paper considers the major effects of cyclosporin A (CsA) in rheumatic diseases (RD). CsA is noted to be effective for a number of RDs and all types of rheumatoid arthritis (RA), including in early RA in adults and juvenile RA; uveitis associated with
Zemfira Sadullaevna Alekberova   +3 more
doaj   +1 more source

Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial

open access: yesIndian Journal of Ophthalmology
Purpose: To investigate the effect of cyclosporine A 2% eye drop following trabeculectomy on intraocular pressure (IOP) and surgical success compared to postoperative steroid drop.
Esmaeil Babaei   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy